Endologix Inc (ELGX)

6.69
NASDAQ : Health Care
Prev Close 6.69
Day Low/High 0.00 / 0.00
52 Wk Low/High 4.78 / 14.49
Avg Volume 2.29M
Exchange NASDAQ
Shares Outstanding 82.77M
Market Cap 533.89M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Commit To Purchase Endologix At $5, Earn 22.8% Annualized Using Options

Commit To Purchase Endologix At $5, Earn 22.8% Annualized Using Options

Investors considering a purchase of Endologix Inc. shares, but cautious about paying the going market price of $6.46/share, might benefit from considering selling puts among the alternative strategies at their disposal.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Endologix, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 6, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Endologix, Inc. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 6, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Endologix, Inc.

ELGX: Insiders vs. Shorts

ELGX: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/31/2017 settlement date, and Endologix Inc. is one of the most shorted stocks of the Russell 3000, based on 9.97 "days to cover" versus the median component at 5.13.

EGLX SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Endologix, Inc. And A Lead Plaintiff Deadline Of March 6, 2017

EGLX SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Endologix, Inc. And A Lead Plaintiff Deadline Of March 6, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased Endologix, Inc.

Endologix Completes Patient Enrollment In The Ovation® LUCY Study

Endologix Completes Patient Enrollment In The Ovation® LUCY Study

First Prospective Study Evaluating EVAR in a Female Population

Endologix Stock Sees Short Interest Jump 24%

Endologix Stock Sees Short Interest Jump 24%

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 3,891,942 share increase in total short interest for Endologix Inc. , to 20,115,723, an increase of 23.99% since 01/13/2017.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Endologix, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 6, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Endologix, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 6, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Endologix, Inc.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Endologix Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Endologix Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf...

Endologix Resumes Shipments Of All Sizes Of AFX®2 Endovascular AAA Systems

Endologix Resumes Shipments Of All Sizes Of AFX®2 Endovascular AAA Systems

Appoints Laura Nagel as Vice President, Global Quality

ELGX LOSS NOTICE: Rosen Law Firm Reminds Endologix, Inc. Investors Of Important Deadline In Class Action Filed By Firm

ELGX LOSS NOTICE: Rosen Law Firm Reminds Endologix, Inc. Investors Of Important Deadline In Class Action Filed By Firm

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Endologix, Inc.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Endologix, Inc. Investors And Encourages Investors To Contact The Firm

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Endologix, Inc. Investors And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Endologix, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Endologix, Inc. - ELGX

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Endologix, Inc. - ELGX

Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of Endologix, Inc.

Week in Review: Trump Rally Fizzles but Stocks End 2016 With Big Gains

Week in Review: Trump Rally Fizzles but Stocks End 2016 With Big Gains

The post-Trump rally came to an end this week, as the Dow missed its 20,000 milestone and stocks ended lower Friday, while finishing 2016 with big gains.

Closing Bell: Wall Street Falls for Second Day; Crude Oil Settles Lower

Closing Bell: Wall Street Falls for Second Day; Crude Oil Settles Lower

Stocks close down Thursday as markets adjust to mixed economic data and the financial sector slumps.

Wall Street Falls Again as Financial Stocks Lead the Decline

Wall Street Falls Again as Financial Stocks Lead the Decline

Stocks slumped for the second consecutive day as markets adjust to mixed economic data and the financial sector led the decline.